A new study by Thomas Jefferson University neuroscientist Jay Schneider, PhD, suggests that the toxic effects of lead can be mitigated by attentive maternal care and an enriched environment in an animal model.

New breakthroughs in understanding gender disparities in liver transplants, the eye’s defenses against disease, and inflammation-related nerve damage in MS.

In a new paper, published in EMBO Reports, a team including Davide Trotti, PhD, a neuroscientist at Thomas Jefferson University, showed how altered glucose metabolism in the brain and spinal cord are damaging to motor neurons in preclinical models that carry the genetic C9-NRE mutation. 

Exploring multimorbidity among aging adults in India; targeting a gut protein to prevent neurodegeneration; repurposing existing therapies for butterfly disease.

Exploring how machine learning can be used to predict cardiac damage, studying the link between substance use during pregnancy and ADHD, and targeting potassium channels in the brain.

Neuroscientist Manuel Covarrubias, MD, PhD and his research assistant Qiansheng Liang, MD led a study published in Nature Communications that focused on Kv3 channels, the subclass of voltage-gated potassium channels that selectively bind AUT5.